Lifevantage Corporation - Common Stock (LFVN)
16.10
-0.72 (-4.28%)
Lifevantage Corp is a biotechnology company that focuses on developing and marketing products designed to promote health and wellness through the activation of the body's natural processes
The company is known for its innovative nutritional supplements and skincare products that leverage the science of cellular health and longevity. By utilizing advanced research and development, Lifevantage aims to empower consumers to enhance their overall well-being and optimize their life's potential through targeted solutions.
When backtesting a portfolio strategy, you have to decide how far back to look. Should you use all available data, stretching back decades? Or should you just look at the last few years? There are arguments to be made for both options.
Via Talk Markets · February 15, 2025

GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.
Via MarketBeat · February 12, 2025

Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
Via Chartmill · February 6, 2025

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 5, 2025

Via Benzinga · October 25, 2024

Via Benzinga · October 14, 2024

Via Benzinga · October 3, 2024

Via Benzinga · September 4, 2023

LFVN stock results show that Lifevantage beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024.
Via InvestorPlace · May 2, 2024

Companies Reporting Before The Bell • CommVault Systems (NASDAQCVLT) is estimated to report quarterly earnings at $0.73 per share on revenue of $208.06 million.
Via Benzinga · January 30, 2024

Via Benzinga · November 17, 2023
Nearly 300 Senior Marketing Consultants Announce Support for Existing LifeVantage Corporation (LFVN) Board of Directors
--News Direct--
Via News Direct · October 12, 2023

Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via Benzinga · September 27, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 250 points on Tuesday. The Dow traded up 0.74% to 34,814.53 while the NASDAQ rose 1.73% to 13,942.34. The S&P 500, also rose, gaining, 1.34% to 4,492.62.
Via Benzinga · August 29, 2023

Gainers Axcella Health Inc. (NASDAQAXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment.
Via Benzinga · August 29, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.57% to 34,758.68 while the NASDAQ rose 1.61% to 13,925.71. The S&P 500, also rose, gaining, 1.13% to 4,483.44.
Via Benzinga · August 29, 2023

Via Benzinga · July 4, 2023

The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies.
Via Benzinga · June 16, 2023

The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies.
Via Benzinga · May 18, 2023